Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells ; volume:9 ; number:1 ; day:1 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (1.3.2019), 1-8, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Shi, Zhong
Yu, Xiaofu
Yuan, Meiqin
Lv, Wangxia
Feng, Tingting
Bai, Rui
Zhong, Haijun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39547-x
- URN
-
urn:nbn:de:101:1-2019032318535792967333
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shi, Zhong
- Yu, Xiaofu
- Yuan, Meiqin
- Lv, Wangxia
- Feng, Tingting
- Bai, Rui
- Zhong, Haijun
- SpringerLink (Online service)
Other Objects (12)
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERk
PERK
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERk
PERK
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERk